Diagnostica Stago Inc. joins AdvaMedDx
April 10, 2012, Parsippany, NJ, USA – Diagnostica Stago, Inc. (DSI) has joined AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) dedicated to addressing the policy and regulatory issues facing in vitro diagnostic companies both in the United States and abroad.
Read more
Stago Offers Three Procoagulant Microparticle Detection Methods
January 4, 2012, Parsippany, NJ, USA – Diagnostica Stago announces three new products to suit a variety of clinical research needs for procoagulant and total microparticle detection. Microparticles are tissue factor-bearing phospholipid vesicles that have often been the subject of clinical research studies into various conditions such as cancer, diabetes, sickle cell disorder, as well as parasitic and viral infections. Research into this topic is currently expanding rapidly, with many studies being communicated frequently at scientific meetings.
Read more
Stago Establishes Stake in Thrombin Generation Through Acquisition of Thrombinoscope BV
July 1, 2011, Parsippany, NJ, USA – Diagnostica Stago, Inc. (DSI), recently finalized the acquisition of Thrombinoscope BV, based in Maastricht, The Netherlands. This company, researches, develops and markets thrombin generation (TG) systems through the use of the Calibrated Automated Thrombogram® (CAT) system. This system is available for research-only use – and should not be used for diagnostic purposes.
Read more
Diagnostica Stago, Inc. Introduces STA-Staclot DRVV Lupus Anticoagulant Assays
October 7, 2010, Parsippany, NJ, USA – Diagnostica Stago, Inc. is pleased to announce the addition of STA-Staclot DRVV Screen and STA Staclot DRVV Confirm lupus anticoagulant (LA) assays. These fully automated assays use the diluted Russell’s viper venom method to detect lupus anticoagulants in patient plasma, and each reagent is bar-coded for ease of use on Stago’s STA analyzers.
Read moreCellquant and Redquant Kits Now Available Exclusively Through Diagnostica Stago
October 1, 2010, Parsippany, NJ, USA – Diagnostica Stago, Inc. (DSI) announces exclusive distribution of the Biocytex Cellquant PNH and Redquant PNH assay kits, previously available through Beckman Coulter. Cellquant and Redquant are no-wash, whole blood, single-color, quantitative, research-use-only flow cytometry assays for analysis of granulocytes and red blood cells, respectively, on samples taken from donors suspected of paroxysmal nocturnal hemoglobinuria (PNH).
Read more